Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
14523963
DOI
10.1002/mrm.10585
Knihovny.cz E-resources
- MeSH
- Bromodeoxyuridine MeSH
- Bone Marrow Cells physiology MeSH
- Dextrans MeSH
- Contrast Media * MeSH
- Rats MeSH
- Magnetic Resonance Imaging MeSH
- Magnetite Nanoparticles MeSH
- Microscopy, Electron, Scanning MeSH
- Brain anatomy & histology MeSH
- Ferrosoferric Oxide MeSH
- Oxides * MeSH
- Cell Movement MeSH
- Rats, Wistar MeSH
- Suspensions MeSH
- Bone Marrow Transplantation MeSH
- Iron * MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Bromodeoxyuridine MeSH
- Dextrans MeSH
- ferumoxides MeSH Browser
- Contrast Media * MeSH
- Magnetite Nanoparticles MeSH
- Ferrosoferric Oxide MeSH
- Oxides * MeSH
- Suspensions MeSH
- Iron * MeSH
Bone marrow stromal cells (MSCs) are pluripotent progenitor cells that have the capacity to migrate toward lesions and induce or facilitate site-dependent differentiation in response to environmental signals. In animals with a cortical photochemical lesion, the fate of rat MSCs colabeled with magnetic iron-oxide nanoparticles (Endorem) and bromodeoxyuridine (BrdU) was studied. MSCs were either grafted intracerebrally into the contralateral hemisphere of adult rat brain or injected intravenously. In vivo MRI was used to track their fate; Prussian blue staining and transmission electron microscopy (TEM) confirmed the presence of iron-oxide nanoparticles inside the cells. During the first week posttransplantation, the transplanted cells migrated to the lesion site and populated the border zone of the damaged cortical tissue. The implanted cells were visible on MR images as a hypointense area at the injection site and in the lesion. The hypointense signal persisted for more than 50 days. The presence of BrdU-positive and iron-containing cells was confirmed by subsequent histological staining. Three to 4 weeks after injection, <3% of MSCs around the lesion expressed the neuronal marker NeuN. Our study demonstrates that a commercially available contrast agent can be used as a marker for the long-term noninvasive MR tracking of implanted cells.
References provided by Crossref.org
Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis
The negative effect of magnetic nanoparticles with ascorbic acid on peritoneal macrophages
Manganese-Zinc Ferrites: Safe and Efficient Nanolabels for Cell Imaging and Tracking In Vivo
Pre-Microporation Improves Outcome of Pancreatic Islet Labelling for Optical and 19F MR Imaging
Bone marrow stem cells and polymer hydrogels--two strategies for spinal cord injury repair